Triptolide Alleviates Oxidized LDL-Induced Endothelial Inflammation by Attenuating the Oxidative Stress-Mediated Nuclear Factor-Kappa B Pathway
Authors:
Open Access
- 21 July 2022
- journal article
- research article
- Published by Elsevier in Current Therapeutic Research
- Vol. 97, 100683
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81673734, 82074194)
This publication has 38 references indexed in Scilit:
- Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-κB pathwaysCell Adhesion & Migration, 2016
- Monocyte trafficking across the vessel wallCardiovascular Research, 2015
- Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS MethodMolecules, 2015
- Treating Coronary Disease and the Impact of Endothelial DysfunctionProgress in Cardiovascular Diseases, 2015
- Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during ExtravasationMediators of Inflammation, 2015
- Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-α-treated endothelial cells via NADPH oxidase-dependent IκB kinase/NF-κB pathwayFree Radical Biology and Medicine, 2015
- Oxidized low-density lipoprotein as a biomarker of cardiovascular diseasesCritical Reviews in Clinical Laboratory Sciences, 2014
- Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cellsJournal of Vascular Surgery, 2010
- Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Enhanced oxidative stress in kidneys of salt-sensitive hypertension: role of sensory nervesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006